BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36856418)

  • 1. A New Phenotype in
    Sala A; Ardizzoni A; Spaggiari L; Vaidya N; van der Schaaf J; Rizzato C; Cermelli C; Mogavero S; Krüger T; Himmel M; Kniemeyer O; Brakhage AA; King BL; Lupetti A; Comar M; de Seta F; Tavanti A; Blasi E; Wheeler RT; Pericolini E
    mBio; 2023 Apr; 14(2):e0010723. PubMed ID: 36856418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
    Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
    Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.
    Bruno VM; Shetty AC; Yano J; Fidel PL; Noverr MC; Peters BM
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis.
    Miao J; Regan J; Cai C; Palmer GE; Williams DL; Kruppa MD; Peters BM
    mBio; 2023 Apr; 14(2):e0004623. PubMed ID: 36840583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis.
    Zhu YX; Shi Y; Fan SR; Liu XP; Yang J; Zhong SL
    BMC Infect Dis; 2019 May; 19(1):461. PubMed ID: 31117966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
    Pang Q; Liu W; Cui F; Kan S; Li X
    Mycopathologia; 2022 Dec; 187(5-6):427-437. PubMed ID: 36209322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence and antifungal susceptibility of microsatellite genotypes of Candida albicans from superficial and deep locations.
    Wang M; Cao Y; Xia M; Al-Hatmi AMS; Ou W; Wang Y; Sibirny AA; Zhao L; Zou C; Liao W; Bai F; Zhi X; de Hoog S; Kang Y
    Yeast; 2019 May; 36(5):363-373. PubMed ID: 31037772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis.
    Valentine M; Rudolph P; Dietschmann A; Tsavou A; Mogavero S; Lee S; Priest EL; Zhurgenbayeva G; Jablonowski N; Timme S; Eggeling C; Allert S; Dolk E; Naglik JR; Figge MT; Gresnigt MS; Hube B
    mBio; 2024 Mar; 15(3):e0340923. PubMed ID: 38349176
    [No Abstract]   [Full Text] [Related]  

  • 14. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.
    Li J; Fan SR; Liu XP; Li DM; Nie ZH; Li F; Lin H; Huang WM; Zong LL; Jin JG; Lei H; Bai FY
    Clin Infect Dis; 2008 Nov; 47(9):1119-25. PubMed ID: 18808351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
    Shao MK; Qi WJ; Hou MY; Luo DD
    J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
    Li X; Chen S; Lyu X; Tian J
    Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
    Gunther LS; Martins HP; Gimenes F; Abreu AL; Consolaro ME; Svidzinski TI
    Sao Paulo Med J; 2014; 132(2):116-20. PubMed ID: 24714993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
    Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.